Amoy Diagnostics, Pierre Fabre Collaborate to Develop CDx in China
The companion diagnostic kits will support marketing authorization applications for Pfizer's Braftovi and Mektovi.
Source: precisiononcologynews.com
Page 28 - Amoy News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Amoy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Amoy Today - Breaking & Trending Today
Merck KGaA's Tepmetko Approved in Europe for NSCLC With MET Exon 14 Alterations
The drug was approved as a monotherapy for previously treated patients, a departure from approvals in the US and Japan for patients regardless of prior treatment.
Source: precisiononcologynews.com
Companion Diagnostics Market worth $9.9 billion by 2026 - Exclusive Report by MarketsandMarkets
CHICAGO, Feb. 8, 2022 /PRNewswire/ -- According to the new market research report "Companion Diagnostics Market by Product (Assays, Kits, Software & Services), Technology (PCR, NGS, ISH
Source: finanznachrichten.de
Companion Diagnostics Market worth $9.9 billion by 2026 - Exclusive Report by MarketsandMarkets™
/PRNewswire/ -- According to the new market research report "Companion Diagnostics Market by Product (Assays, Kits, Software & Services), Technology (PCR, NGS,...
Source: prnewswire.com